Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the ....
Awaiting price reaction for this filing.
The Board of Directors of Bijoy Hans Ltd, held on January 31, 2026, approved several key items. CA Manali Aditya Pandit has been appointed as a Non-Executive Women Independent Director for a 5-year term (January 31, 2026 to January 30, 2031); she is a Chartered Accountant with 9 years of experience in internal audit, finance, and business process management. The Board also approved a proposal to change the company's name from 'Bijoy Hans Limited' to 'Arvaya Healthtech Limited', subject to regulatory approvals, to better reflect the company's business activities and vision. An Extra Ordinary General Meeting (EGM) has been scheduled for February 25, 2026 at 3:00 PM via video conferencing to seek shareholder approval on these matters, with e-voting from February 22 to February 24, 2026. CS Chinmay Mohan Lele has been appointed as Scrutinizer for the e-voting process. The Board meeting concluded at 3:30 PM.
The proposed name change to 'Arvaya Healthtech Limited' signals a potential strategic pivot or rebranding, which could affect investor perception and brand identity going forward. The new independent director brings financial expertise to the board. Shareholders will need to vote on the name change at the EGM on February 25, 2026.